Cadrenal Therapeutics, Inc. Common Stock

CVKD

CVKDCadrenal Therapeutics, Inc. Common Stock US flag

NASDAQ Global Market

4.35

USD

-0.35

- -

12.48MMarket Cap

Income Statement (USD)

API Chat

	2022 Y	2023 Y	2024 Y	2025 Y
Sales/Revenue/Turnover	- -	- -	- -	- -
+ Sales & Services Revenue	- -	- -	- -	- -
- Cost of Revenue	- -	- -	- -	- -
+ Cost of Goods & Services	- -	- -	- -	- -
Gross Profit	- -	- -	- -	- -
+ Other Operating Income	- -	- -	- -	- -
- Operating Expenses	- -	8	11	13
+ Selling, General & Admin	- -	4	7	9
+ Research & Development	- -	4	4	4
+ Other Operating Expense	- -	- -	- -	- -
Operating Income (Loss)	- -	-8	-11	-13
- Non-Operating (Income) Loss	- -	1	- -	- -
+ Interest Expense, Net	- -	- -	- -	- -
+ Interest Expense	- -	- -	- -	- -
- Interest Income	- -	- -	- -	- -
+ Other Non-Op (Income) Loss	- -	1	- -	- -
Pretax Income	- -	-8	-11	-13
- Income Tax Expense (Benefit)	- -	- -	- -	- -
- (Income) Loss from Affiliates	- -	- -	- -	- -
Income (Loss) from Cont Ops	- -	-8	-11	-13
- Net Extraordinary Losses (Gains)	- -	- -	- -	- -
+ Discontinued Operations	- -	- -	- -	- -
+ Extraord. & Accounting Changes	- -	- -	- -	- -
Income (Loss) Incl. MI	- -	-8	-11	-13
- Minority Interest	- -	- -	- -	- -
Net Income, GAAP	- -	-8	-11	-13
- Preferred Dividends	- -	- -	- -	- -
- Other Adjustments	- -	- -	- -	- -
Net Income Avail to Common, GAAP	- -	-8	-11	-13
EBIT	- -	-8	-11	-13
EBITDA	- -	-8	-11	-13
EBITDA Margin (%)	- -	- -	- -	- -
EBITA	- -	-8	-11	-13
Gross Margin (%)	- -	- -	- -	- -
Operating Margin (%)	- -	- -	- -	- -
Profit Margin (%)	- -	- -	- -	- -
Sales per Employee	- -	- -	- -	- -
Dividend per Share	- -	- -	- -	- -
Depreciation Expense	- -	- -	- -	- -
Basic Weighted Avg Shares	- -	1	1	- -
Basic EPS, GAAP	- -	-9.29	-8.73	- -
Basic EPS from Cont Ops	- -	-9.29	-8.73	- -
Diluted Weighted Avg Shares	- -	1	1	- -
Diluted EPS, GAAP	- -	-9.29	-8.73	- -
Diluted EPS from Cont Ops	- -	-9.29	-8.73	- -

Balance Sheet (USD)

API Chat

	2022 Y	2023 Y	2024 Y	2025 Y
Total Current Assets	1	8	10	4
+ Cash, Cash Equivalents & STI	- -	8	10	4
+ Cash & Cash Equivalents	- -	8	10	4
+ ST Investments	- -	- -	- -	- -
+ Accounts & Notes Receiv	- -	- -	- -	- -
+ Accounts Receivable, Net	- -	- -	- -	- -
+ Notes Receivable, Net	- -	- -	- -	- -
+ Loans Receivable, Net	- -	- -	- -	- -
+ Other Receivable, Net	- -	- -	- -	- -
+ Inventories	- -	- -	- -	- -
+ Raw Materials	- -	- -	- -	- -
+ Work In Process	- -	- -	- -	- -
+ Finished Goods	- -	- -	- -	- -
+ Inventory Adjustments	- -	- -	- -	- -
+ Other Inventory	- -	- -	- -	- -
+ Other ST Assets	1	- -	- -	- -
+ Misc ST Assets	- -	- -	- -	- -
+ Prepaid Expenses	- -	- -	- -	- -
+ ST Derivative & Hedging Assets	- -	- -	- -	- -
+ ST Assets Held-for-Sale	- -	- -	- -	- -
+ ST Deferred Tax Assets	- -	- -	- -	- -
Total Noncurrent Assets	- -	- -	- -	- -
+ Property, Plant & Equip, Net	- -	- -	- -	- -
+ Property, Plant & Equip	- -	- -	- -	- -
- Accumulated Depreciation	- -	- -	- -	- -
+ LT Investments & Receivables	- -	- -	- -	- -
+ LT Investments	- -	- -	- -	- -
+ LT Receivables	- -	- -	- -	- -
+ Other LT Assets	- -	- -	- -	- -
+ Total Intangible Assets	- -	- -	- -	- -
+ Goodwill	- -	- -	- -	- -
+ Other Intangible Assets	- -	- -	- -	- -
+ LT Deferred Tax Assets	- -	- -	- -	- -
+ LT Derivative & Hedging Assets	- -	- -	- -	- -
+ Misc LT Assets	- -	- -	- -	- -
Total Assets	1	9	10	4
+ Payables & Accruals	1	- -	2	1
+ Accounts Payable	- -	- -	2	1
+ Accrued Taxes	- -	- -	- -	- -
+ Interest & Dividends Payable	- -	- -	- -	- -
+ Other Payables & Accruals	- -	- -	- -	- -
+ ST Debt	- -	- -	- -	- -
+ ST Borrowings	- -	- -	- -	- -
+ ST Finance Leases	- -	- -	- -	- -
+ Other ST Liabilities	1	1	1	1
+ Deferred Revenue	- -	- -	- -	- -
+ Derivatives & Hedging	- -	- -	- -	- -
+ Deferred Tax Liabilities	- -	- -	- -	- -
+ Misc ST Liabilities	1	1	1	1
Total Current Liabilities	1	1	3	2
+ LT Debt	1	- -	- -	- -
+ LT Borrowings	1	- -	- -	- -
+ LT Finance Leases	- -	- -	- -	- -
+ Other LT Liabilities	4	- -	- -	- -
+ Accrued Liabilities	- -	- -	- -	- -
+ Pension Liabilities	- -	- -	- -	- -
+ Deferred Revenue	- -	- -	- -	- -
+ Deferred Tax Liabilities	- -	- -	- -	- -
+ Derivatives & Hedging	- -	- -	- -	- -
+ Misc LT Liabilities	4	- -	- -	- -
Total Noncurrent Liabilities	5	- -	- -	- -
Total Liabilities	6	1	3	2
+ Preferred Equity and Hybrid Capital	- -	- -	- -	- -
+ Share Capital & APIC	1	23	33	42
+ Common Stock	- -	- -	- -	- -
+ Additional Paid in Capital	1	23	33	42
- Treasury Stock	- -	- -	- -	- -
+ Retained Earnings	-7	-15	-26	-39
+ Other Equity	- -	- -	- -	- -
Equity Before Minority Interest	-6	8	7	3
+ Minority/Non Controlling Interest	- -	- -	- -	- -
Total Equity	-6	8	7	3
Total Liabilities & Equity	1	9	10	4
Shares Outstanding	1	1	2	2
Number of Employees	- -	- -	- -	- -
Capital Leases - Total	- -	- -	- -	- -
Net Debt	1	-8	-10	-4
Net Debt to Equity	-10.17	-109.23	-134.66	-146.34
Tangible Common Equity Ratio	-713.36	90.29	73.49	63.3
Current Ratio	0.55	10.27	3.77	2.72
Cash Conversion Cycle	- -	- -	- -	- -

Cash Flow Statement (USD)

API Chat

	2022 Y	2023 Y	2024 Y	2025 Y
+ Net Income	- -	-8	-11	-13
+ Depreciation & Amortization	- -	- -	- -	- -
+ Non-Cash Items	- -	5	1	2
+ Stock-Based Compensation	- -	1	1	2
+ Deferred Income Taxes	- -	- -	- -	- -
+ Asset Impairment Charge	- -	- -	- -	- -
+ Other Non-Cash Adj	- -	4	- -	- -
+ Chg in Non-Cash Work Cap	- -	- -	2	-1
+ (Inc) Dec in Accts Receiv	- -	- -	- -	- -
+ (Inc) Dec in Inventories	- -	- -	- -	- -
+ (Inc) Dec in Prepaid Assets	- -	- -	- -	- -
+ Inc (Dec) in Accts Payable	- -	- -	2	-1
+ Inc (Dec) in Other	- -	1	- -	- -
+ Net Cash From Disc Ops	- -	- -	- -	- -
Cash from Operating Activities	- -	-4	-7	-13
+ Change in Fixed & Intang	- -	- -	- -	- -
+ Disp in Fixed & Intang	- -	- -	- -	- -
+ Disp of Fixed Prod Assets	- -	- -	- -	- -
+ Disp of Intangible Assets	- -	- -	- -	- -
+ Acq of Fixed & Intang	- -	- -	- -	- -
+ Acq of Fixed Prod Assets	- -	- -	- -	- -
+ Acq of Intangible Assets	- -	- -	- -	- -
+ Cash (Repurchase) of Equity	- -	12	5	7
+ Increase in Capital Stock	- -	12	5	7
+ Decrease in Capital Stock	- -	- -	- -	- -
+ Net Change in LT Investment	- -	- -	- -	- -
+ Dec in LT Investment	- -	- -	- -	- -
+ Inc in LT Investment	- -	- -	- -	- -
+ Net Cash From Acq & Div	- -	- -	- -	- -
+ Cash from Divestitures	- -	- -	- -	- -
+ Cash for Acq of Subs	- -	- -	- -	- -
+ Cash for JVs	- -	- -	- -	- -
+ Other Investing Activities	- -	- -	- -	- -
+ Net Cash From Disc Ops	- -	- -	- -	- -
Cash from Investing Activities	- -	- -	- -	- -
+ Dividends Paid	- -	- -	- -	- -
+ Net Cash From Debt	- -	- -	- -	- -
+ Cash From Debt	- -	- -	- -	- -
+ Repayments of Debt	- -	- -	- -	- -
+ Other Financing Activities	- -	- -	4	- -
+ Net Cash From Disc Ops	- -	- -	- -	- -
Cash from Financing Activities	- -	12	9	7
Effect of Foreign Exchange Rates	- -	- -	- -	- -
Net Changes in Cash	- -	8	2	-6
EBITDA	- -	-8	-11	-13
EBITDA Margin (%)	- -	- -	- -	- -
Free Cash Flow	- -	-4	-7	-13
Net Cash Paid for Acquisitions	- -	- -	- -	- -
Free Cash Flow to Firm	- -	- -	- -	- -
Free Cash Flow to Equity	- -	-4	-7	-13
Free Cash Flow per Basic Share	- -	-3.93	-6.04	- -
Price/Free Cash Flow	- -	-2.83	-2.4	- -
Cash Flow to Net Income	- -	0.42	0.69	0.95
Capital Expenditures	- -	- -	- -	- -